Style | Citing Format |
---|---|
MLA | Alarconsanchez MA, et al.. "Relationship Between Mcp-1 Levels in Gcf and Periodontitis: A Systematic Review With Meta-Analysis and Analysis of Molecular Interactions." Journal of Cellular and Molecular Medicine, vol. 29, no. 9, 2025, pp. -. |
APA | Alarconsanchez MA, Rodriguezmontano R, Lomelimartinez SM, Heboyan A (2025). Relationship Between Mcp-1 Levels in Gcf and Periodontitis: A Systematic Review With Meta-Analysis and Analysis of Molecular Interactions. Journal of Cellular and Molecular Medicine, 29(9), -. |
Chicago | Alarconsanchez MA, Rodriguezmontano R, Lomelimartinez SM, Heboyan A. "Relationship Between Mcp-1 Levels in Gcf and Periodontitis: A Systematic Review With Meta-Analysis and Analysis of Molecular Interactions." Journal of Cellular and Molecular Medicine 29, no. 9 (2025): -. |
Harvard | Alarconsanchez MA et al. (2025) 'Relationship Between Mcp-1 Levels in Gcf and Periodontitis: A Systematic Review With Meta-Analysis and Analysis of Molecular Interactions', Journal of Cellular and Molecular Medicine, 29(9), pp. -. |
Vancouver | Alarconsanchez MA, Rodriguezmontano R, Lomelimartinez SM, Heboyan A. Relationship Between Mcp-1 Levels in Gcf and Periodontitis: A Systematic Review With Meta-Analysis and Analysis of Molecular Interactions. Journal of Cellular and Molecular Medicine. 2025;29(9):-. |
BibTex | @article{ author = {Alarconsanchez MA and Rodriguezmontano R and Lomelimartinez SM and Heboyan A}, title = {Relationship Between Mcp-1 Levels in Gcf and Periodontitis: A Systematic Review With Meta-Analysis and Analysis of Molecular Interactions}, journal = {Journal of Cellular and Molecular Medicine}, volume = {29}, number = {9}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Alarconsanchez MA AU - Rodriguezmontano R AU - Lomelimartinez SM AU - Heboyan A TI - Relationship Between Mcp-1 Levels in Gcf and Periodontitis: A Systematic Review With Meta-Analysis and Analysis of Molecular Interactions JO - Journal of Cellular and Molecular Medicine VL - 29 IS - 9 SP - EP - PY - 2025 ER - |